🇺🇸 FDA
Patent

US 8822434

Compositions and methods to treat cardiac diseases

granted A61KA61K31/675A61K31/683

Quick answer

US patent 8822434 (Compositions and methods to treat cardiac diseases) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/675, A61K31/683, A61P, A61P9/00